© Borgis - Medycyna Rodzinna 2/2018, s. 168
The recent emergence of alternative forms of nicotine delivery (electronic cigarettes, smokeless cigarettes) in the consumer market has contributed to an increased interest in tobacco products, which are often unjustly identified with nicotine. Consequently, a growing number of publications on these products may be observed.
The current issue of „Family Medicine” features three papers in the „Harm Reduction” section. The first article discusses barriers to risk minimisation in individuals who are not able to completely abandon the use of nicotine. According to the author, these include stereotypes about the harmful effects of e-cigarettes, shortcomings in legislation and market regulation, the lack of trust and dialogue between key groups that shape the nicotine product market, as well as the untapped potential of financial motivation among tobacco product users. The author emphasises that the implementation of tools for reducing tobacco smoking should take into account the area of harm reduction rather than just an abstinence approach – as has been globally accepted in the aspect of psychoactive substance dependence for more than two decades.
Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Płatny dostęp do wszystkich zasobów Czytelni Medycznej